How Novo Nordisk misread the US market for its weight loss sensation

finance.yahoo.com/news/novo-nordisk-misread-us-market-100649222.html

In This Article:
By Jacob Gronholt-Pedersen and Maggie Fick
COPENHAGEN (Reuters) -Novo Nordisk's (NVO) top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its weight-loss drug Wegovy, leaving the Danish drugmaker in a more vulnerable…

This story appeared on finance.yahoo.com, 2025-07-01 10:06:49.
The Entire Business World on a Single Page. Free to Use →